Scholars Central

Conference abstractPublished 8 May 2017

Search for new potential biomarkers of non-alcoholic fatty liver disease progression in morbid obese patients

Authors: Xiangping LIN, Mohamed TRIBA, Nadia BOUCHEMAL, Carina Prip-Buus, Philippe SAVARIN

University of Paris 13, France

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The aim of this study was to uncover new potential biomarkers of Non-Alcoholic Fatty Liver Disease (NAFLD) progression in morbid obese patients (BMIâÂ?¥36kg/m2) referred for bariatric surgery. Liver biopsy and plasma of Non-NAFLD obese, histology-confirmed steatoses obese and histology-confirmed advanced grade of NAFLD: Non-alcoholic steatohepatitis (NASH) obese patients were obtained during bariatric surgery. After randomized, eligible liver sample was examined by HR-MAS 1H-NMR spectroscopy, eligible plasma of Non-NAFLD obese (n=18), steatoses obese (n=32) and NASH obese (n=21) patients were analyzed by a 500M Hz 1H-NMR spectroscopy. So far, Orthogonal Projections to Latent Structures Discriminant Analysis (OPLS-DA) shows clear separation between Non-NAFLD obese and NASH obese patients, OPLS-DA and PLS-DA models were evaluated by internal 7-fold cross validation with Cross Validation Area Under Receiver Operating Characteristic (CV-AUROC) > 0.90 for Liver biopsy OPLS-DA model and CV-AUROC > 0.93 for plasma PLS-DA model. Plasma metabolites such as VLDL/LDL, lipid -CH2CH2CO, lipid -CH2CH=CH and lipid -CH2CO were significantly higher in NASH obese than in Non-NAFLD obese patients, plasma metabolomic profile appears to correlate with HR-MAS 1H-NMR liver biopsy metabolomic profile. Because of NMR resolution limit, those plasma samples will also analysis by a High-resolution mass spectrometry to get detail information on metabolites such as VLDL/LDLs, triglycerides, nonesterified fatty acids, phosphatidylcholines and ceramides. Furthermore, combing biochemical, genomic and transcriptomic data our study may shed light on mechanisms of mitochondrial dysfunction, hepatic lipid metabolism alterations during NAFLD progression.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMetabolomics:Open Access
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Xiangping LIN”
  • BylineArticles whose byline prints “Mohamed TRIBA”
  • BylineArticles whose byline prints “Nadia BOUCHEMAL”
  • BylineArticles whose byline prints “Carina Prip-Buus”
  • BylineArticles whose byline prints “Philippe SAVARIN”